HIF1A and nonpapillary renal cell carcinoma: In ccRCC tumors, the loss-of-function mutations of von Hippel–Lindau tumor suppressor (VHL), an E3 ubiquitin ligase that targets HIF1α under normoxic conditions, are usually responsible for hypoxia response activation (22, 23).